EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets

Jean-Ehrland Ricci

Cell Reports · 2025-01 · 44 (1) · 115206

DOI: 10.1016/j.celrep.2024.115206 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Reports, 2025-01. Verfasst von Jean-Ehrland Ricci. Beteiligte Einrichtung: Université Côte d'Azur, INSERM, C3M, Nice, France; Équipe labellisée LIGUE Contre le Cancer, Nice, France. Electronic address: ricci@unice.fr. Hauptthemen laut MEDLINE: Neoplasms, Immunosuppression Therapy, Immune Tolerance. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canceropôle PACA, French National Cancer Institute, Labex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming in both immune and cancer cells plays a crucial role in the antitumor immune response. Recent studies indicate that cancer metabolism not only sustains carcinogenesis and survival via altered signaling but also modulates immune cell function. Metabolic crosstalk within the tumor microenvironment results in nutrient competition and acidosis, thereby hindering immune cell functionality. Interestingly, immune cells also undergo metabolic reprogramming that enables their proliferation, differentiation, and effector functions. This review highlights the regulation of antitumor immune responses through metabolic reprogramming in cancer and immune cells and explores therapeutic strategies that target these metabolic pathways in cancer immunotherapy, including using chimeric antigen receptor (CAR)-T cells. We discuss innovative combinations of immunotherapy, cellular therapies, and metabolic interventions that could optimize the efficacy of existing treatment protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunosuppression TherapyImmune ToleranceHumansTumor MicroenvironmentAnimalsImmunotherapy

Stichwörter der Autor:innen

CP: CancerCP: Metabolismantitumor activity of immune cellscancermetabolismtherapeutic strategiestumor microenvironment

Autor:innen und Institutionen

  • Université Côte d'Azur, INSERM, C3M, Nice, France; Équipe labellisée LIGUE Contre le Cancer, Nice, France. Electronic address: ricci@unice.fr.

Förderung

  • Canceropôle PACA
  • French National Cancer Institute
  • Labex
  • Foundation of France
  • Agence Nationale de la Recherche
  • Ligue Contre le Cancer
  • Association pour la Recherche sur le Cancer

Zitieren

APA

Ricci, J. E. (2025). Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets. Cell Reports, 44(1), 115206. https://doi.org/10.1016/j.celrep.2024.115206

Vancouver

Ricci JE. Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets. Cell Reports. 2025;44(1):115206. doi:10.1016/j.celrep.2024.115206

BibTeX
@article{Ricci2025,
  author = {Ricci, Jean-Ehrland},
  title = {Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {1},
  pages = {115206},
  doi = {10.1016/j.celrep.2024.115206}
}
Kostenlos starten →